{
    "organizations": [],
    "uuid": "98849017d85d12c85ea8b0f96df44a7c83f4c5f7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-jordans-philadelphia-pharmaceutica/brief-jordans-philadelphia-pharmaceuticals-fy-profit-rises-idUSL8N1Q22HX",
    "ord_in_thread": 0,
    "title": "BRIEF-Jordan's Philadelphia Pharmaceuticals FY Profit Rises",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 12 (Reuters) - PHILADELPHIA PHARMACEUTICALS INDUSTRY COMPANY:\n* FY NET PROFIT ATTRIBUTABLE TO SHAREHOLDERS 856,496 DINARS VERSUS 655,393 DINARS YEAR AGO\n* FY NET OPERATING REVENUE 6.9‍​ MILLION DINARS VERSUS 6.8 ‍​MILLION DINARS YEAR AGO Source: ( bit.ly/2Cgahza ) Further company coverage:\n ",
    "published": "2018-02-12T18:31:00.000+02:00",
    "crawled": "2018-02-13T15:33:14.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "philadelphia",
        "pharmaceutical",
        "industry",
        "company",
        "fy",
        "net",
        "profit",
        "attributable",
        "shareholder",
        "dinar",
        "versus",
        "dinar",
        "year",
        "ago",
        "fy",
        "net",
        "operating",
        "revenue",
        "million",
        "dinar",
        "versus",
        "dinar",
        "year",
        "ago",
        "source",
        "company",
        "coverage"
    ]
}